Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-28
2007-08-28
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S260100, C514S249000, C514S252100, C514S234200, C514S221000, C544S255000, C544S230000, C544S117000, C540S575000, C540S492000, C540S470000, C540S460000, C540S504000
Reexamination Certificate
active
10497385
ABSTRACT:
The present invention relates to azolopyriniidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
REFERENCES:
patent: 5977118 (1999-11-01), Bacon et al.
patent: 6489134 (2002-12-01), Goldstein et al.
patent: 0999211 (2000-05-01), None
patent: WO96/28429 (1996-09-01), None
patent: WO98/14451 (1998-04-01), None
patent: WO 01 25242 (2001-04-01), None
patent: WO 01 30768 (2001-05-01), None
patent: WO 01 74344 (2001-10-01), None
Coleman, P.J.; Fraley, M. E.; Expert. Opin. Ther. Patents; 2004; 14(12); 1659-1667.
Cancer Mangement: A Multidisciplinary Approach, Publishers of Oncology, 2005-2006, 9th Edition, Chapter 26, 615-638.
Colorectal Cancer Coalition, <http://www.fightcolorectalcancer.org/patients/diagnosis/rctreatment.htm> downloaded from the internet Nov. 27, 2006.
Cancer Research 64, pp. 3276-3280, May 1, 2004, by R. Sakowicz, et al.
K. M. Lakin, et al., Database Accession No. 1980:174544 Biologii i Meditsiny, 89(2), 181-2 (1980) CAS printout of structure and abstract.
G. Biagi, et al., Farmaco, 51(4), pp. 301-303 (1996).
M. Hocek, et al., Synthesis (12), pp. 1401-1402 (1994).
P. L. Barili, et al., Journal of Heterocyclic Chemistry, 22(6), pp. 1607-1609 (1985).
I. M. Ovcharova, et al., Database Accession No. 1967:500110, Khimiko-Farmatsevticheskii Zhurnal, 1(3), pp. 37-40 (1967) CAS printout of structure and abstract.
I. M. Ovcharova, et al., Database Accession No. 1965:82560, Zhurnal Obshcheikhimii, 34(10), pp. 3254-3259 (1964) CAS printout of structure and abstract.
Fraley Mark E.
Hartman George D.
Hoffman William F.
Beeler Nicole M.
Berch Mark L.
Merck & Co. , Inc.
Moore Susanna
Muthard David A.
LandOfFree
Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3868903